Cytogenetic findings in mantle cell lymphoma: Cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities

American Journal of Clinical Pathology

Volumn 116, Issue 6, 2001, Pages 886-892

  Onciu, M ^a   Schlette, E ^a   Medeiros, L J ^a   Abruzzo, L V ^a   Keating, M ^a   Lai, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Conventional cytogenetics; Leukemia; Lymph node; Mantle cell lymphoma

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTOSIS; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; FEMALE; HUMANS; LYMPH NODES; LYMPHOCYTOSIS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED;

EID: 0035180862     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/JQMR-323G-71Y9-M7MB     Document Type: Article

References (35)

1. Mantle cell lymphoma: An entity comes of age
2. Rearrangement and overexpression of the Bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and t(11q13)-bearing leukemias
3. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma
4. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation
5. Mantle cell lymphoma: A clinicopathologic study of 80 cases
6. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
7. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features
8. 13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features
9. Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma
10. Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: A fluorescence in situ hybridization study
11. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
12. Cytogenetic abnormalities in the leukemic phase of non-Hodgkin's lymphoma
13. Secondary chromosome changes in mantle cell lymphoma
14. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
15. Molecular characterization of 11q deletions points to a pathogenetic role of the ATM gene in mantle cell lymphoma
16. Bone marrow and peripheral blood involvement in mantle cell lymphoma
17. Mantle cell lymphomas: Characteristics, natural history and prognostic factors in 45 cases
18. Prognostic significance of bone marrow trephine and peripheral bone marrow smears in 55 patients with mantle cell lymphoma
19. Leukemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): A subtype of mantle cell lyrnphoma?
20. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
21. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
22. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in the lymphomagenesis with the myc gene
23. Cyclin D1/bcl1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice
24. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type and survival in patients with B-cell non-Hodgkin's lymphoma
25. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)
26. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features
27. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis
28. A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral T-cell lymphomas?
29. Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer
30. Prognostic value of cytogenetics in multiple myeloma
31. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34
32. Age-associated aneuploidy: Loss of Y chromosome from human bone marrow cells with aging
33. United Kingdom Cancer Cytogenetics Group (UKCCG) Loss of the Y chromosome from normal and neoplastic bone marrows
34. Clinical significance of Y chromosome loss in hematologic disease